冠状动脉微血管功能障碍与射血分数保留心衰的未来风险
本研究纳入201例疑似冠心病但无血流限制性病变且左室射血分数正常的患者,通过应激心肌灌注正电子发射断层扫描、血清肌钙蛋白和经胸超声心动图评估,随访中位4.1年。结果显示冠状动脉血流储备受损(<2)与舒张功能障碍独立相关,并与心血管不良事件及HFpEF住院风险独立相关;微血管功能障碍合并舒张功能障碍者HFpEF住院风险增加超过五倍。
要点
- 无显著冠心病症状患者中,CFR受损(<2)与舒张功能恶化线性相关。
- CFR受损独立关联舒张功能障碍(E/e'室间隔>15)及不良心血管结局。
- CFR受损合并舒张功能障碍者HFpEF住院风险增加超过五倍。
核心结论
- 在无显著冠心病的症状性患者中,冠状动脉血流储备受损独立关联舒张功能障碍和不良事件,尤其是HFpEF住院。
- 冠状动脉微血管功能障碍与舒张功能障碍并存时,HFpEF事件风险显著增加。
研究设计与样本
- 连续纳入201例因疑似冠心病接受负荷心肌灌注正电子发射断层扫描、血清肌钙蛋白和经胸超声心动图评估的患者。
- 纳入标准为无血流限制性冠心病且左室射血分数未降低,随访中位4.1年。
- 冠状动脉血流储备以负荷/静息心肌血流量量化, impaired CFR定义为<2。
主要发现
- 108例患者CFR受损(<2),其e'线性降低、E/e'升高,与舒张功能恶化一致(趋势P<0.0001)。
- 可检测的肌钙蛋白仅在CFR受损时与舒张功能障碍相关(交互作用P=0.002)。
- 校正分析中,CFR受损独立关联舒张功能障碍(E/e'室间隔>15,校正OR 2.58,95%CI 1.22-5.48)。
- 校正分析中,CFR受损独立关联复合心血管结局或HFpEF住院(校正HR 2.47,95%CI 1.09-5.62)。
- CFR受损合并舒张功能障碍者HFpEF住院风险增加超过五倍(P<0.001)。
关键数值与推荐
- CFR受损定义为<2。
- 舒张功能障碍采用E/e'室间隔>15作为指标。
- 复合结局包括心血管死亡、非致命性心肌梗死或心力衰竭住院。
临床怎么用
- 对疑似冠心病但无血流限制性病变的症状性患者,可评估CFR以识别HFpEF高风险人群。
- CFR受损合并舒张功能障碍提示HFpEF住院风险显著增高,需加强监测与干预。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Coronary microvascular ischaemia, cardiomyocyte injury and stiffness may play an important role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). To date, the relationship between coronary flow reserve (CFR), myocardial injury, diastolic dysfunction, and future HFpEF risk is unknown. METHODS AND RESULTS: Consecutive patients (n = 201) undergoing evaluation for suspected coronary artery disease (CAD) with stress myocardial perfusion positron emission tomography, serum troponin, and transthoracic echocardiography who did not have flow-limiting CAD or reduced left ventricular ejection fraction were identified. Patients were followed up (median 4.1 years) for cardiovascular death and hospitalization for non-fatal myocardial infarction or heart failure. Coronary flow reserve was quantified as stress/rest myocardial blood flow. Early diastolic flow (E) and relaxation (e') velocities were obtained via transmitral and tissue Doppler, respectively. Patients with impaired CFR (<2, n = 108) demonstrated linearly decreasing e' and increasing E/e' consistent with worsening diastolic function (P for trend <0.0001). A detectable troponin was associated with diastolic dysfunction only in the presence of impaired CFR (interaction P = 0.002). In adjusted analyses, impaired CFR was independently associated with diastolic dysfunction (E/e'septal > 15, adjusted OR 2.58, 95%CI 1.22-5.48) and composite cardiovascular outcomes or HFpEF hospitalization alone (adjusted HR 2.47, 95%CI 1.09-5.62). Patients with both impaired CFR and diastolic dysfunction demonstrated >five-fold increased risk of HFpEF hospitalization (P < 0.001). CONCLUSION: In symptomatic patients without overt CAD, impaired CFR was independently associated with diastolic dysfunction and adverse events, especially HFpEF hospitalization. The presence of both coronary microvascular and diastolic dysfunctions was associated with a markedly increased risk of HFpEF events.
引用
- Taqueti VR, Solomon SD, Shah AM, et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction. Eur Heart J. 2018. PMID: 29293969. doi:10.1093/eurheartj/ehx721
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。